Corinne Godin - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Corinne Godin

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Cancer Letters|November 8, 2015

Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenibAline Houessinon, Albane Gicquel, Flora Bochereau, et al.

Molecular Cancer Research : MCR|July 22, 2010

BAD, a proapoptotic member of the BCL2 family, is a potential therapeutic target in hepatocellular carcinomaAntoine Galmiche, Zakaria Ezzoukhry, Catherine François, et al.

Molecular Cancer|May 18, 2016

Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenibAline Houessinon, Catherine François, Chloé Sauzay, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Cancer Letters|November 8, 2015

Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenibAline Houessinon, Albane Gicquel, Flora Bochereau, et al.

Molecular Cancer Research : MCR|July 22, 2010

BAD, a proapoptotic member of the BCL2 family, is a potential therapeutic target in hepatocellular carcinomaAntoine Galmiche, Zakaria Ezzoukhry, Catherine François, et al.

Molecular Cancer|May 18, 2016

Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenibAline Houessinon, Catherine François, Chloé Sauzay, et al.

Pageof 3